Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38
US11021543B2 · kind B2 · utility
10Cited by
18References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2018 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Dec 20, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of immunomodulation and treating patients having solid tumors with antibodies that specifically bind CD38.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.